第一年肺支气管发育不良:严重程度,药物使用和医疗保健利用的洞察
Eliaz Brumer1,2, Veronika Shabanova2,3, Haley Urbach2
1Department of Pediatrics, Section of Pulmonary, Allergy-Immunology, and Sleep Medicine, Yale University, New Haven, Connecticut, USA.
Pediatric pulmonology
|August 26, 2025
概括
患有支气管肺功能障碍 (BPD) 的婴儿在出院后面临严重的呼吸问题和医疗保健需求,随着疾病的严重程度而增加. 对于所有BPD患者来说,无论严重程度如何,结构化的随访对于控制呼吸道疾病至关重要.
科学领域:
- 新生儿医学
- 儿童肺病学
- 呼吸系统医学
背景情况:
- 支气管肺功能障碍 (BPD) 是早产婴儿中普遍存在的慢性肺部疾病.
- 了解BPD严重程度对呼吸系统结果和医疗保健使用的影响对于优化护理至关重要.
- 需要进一步描述NICU干预的作用,如德克萨米和NICU后的随访.
研究的目的:
- 检查BPD严重程度与NICU后呼吸结果和医疗保健利用之间的关联.
- 评估门诊儿科肺病随访对呼吸道疾病的影响.
- 评估在婴儿重症监护室停留期间服用德克萨梅他对出院后呼吸系统健康的影响.
主要方法:
- 使用2019年严重程度分类对161名被诊断患有BPD的婴儿进行回顾性队列研究 (2021-2023年).
- 评估的主要结果:药物处方 (阿尔布特罗尔,吸入/全身类固醇),急救诊所和NICU出院后的一年内住院.
- 德克萨梅他使用情况,肺部病理随访情况和呼吸道疾病相关情况.
主要成果:
- BPD严重程度分布:32.9%为1级,59.0%为2级,8.1%为3级.
- 随着BPD的严重程度,使用德克萨米他和肺部检查的比率增加 (p< 0. 001).
- 近一半 (47.2%) 的患者在出院后住院治疗呼吸系统问题; 22.3% 的患者住院治疗.
结论:
- 患有BPD的婴儿的呼吸道发病率和医疗利用率随着疾病的严重程度而增加.
- 在所有严重程度的BPD,包括较轻微的病例中,呼吸医院访问的负担很大.
- 对于所有患有BPD的婴儿来说,结构化的纵向跟踪对于缓解呼吸系统疾病至关重要.
相关概念视频
Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids
307
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307
Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K


